Evaluating treatment for asymptomatic common bile duct stones

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, multicenter study aims to identify the characteristics and treatment effectiveness of asymptomatic common bile duct stones. It will compare patient-reported outcomes before and after the removal of these stones using endoscopic retrograde cholangiopancreatography. Additionally, the study will follow patients who opt not to undergo removal to assess the risk of cholangitis and document the complication rates associated with the procedure. The findings will help clarify the management of asymptomatic cases identified through routine imaging.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* diagnosed as common bile duct stone by image modality examination
* agreement for this study enrollment

Exclusion Criteria:

* no definite common bile duct stone by image modality examination
* symptomatic patients who complain with fever/abdominal pain that compatible with common bile duct stone related symptom
* previously diagnosed as pancreatobiliary malignancy
* previously treated by endoscopic or percutaneous treatment for bile duct stones
* severe cardio or pulmonary disease
* pregnancy or possibility of pregnancy
* who do not agree with study enrollment

Where it's running

• Kyungpook National University Hospital
  Daegu, Gyungsangbok-do, South Korea Recruiting

Study contacts

• Study coordinator: Jun Heo
• Email: hero797@hanmail.net
• Phone: 82532005505

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Hyoscine Butylbromide During Transcystic Papillary Balloon Dilation for Choledocholithiasis

  This study tests whether giving hyoscine butylbromide during laparoscopic transcystic papillary balloon dilation helps patients with common bile duct stones by making the procedure faster or easier.

  Recruiting Riga East Clinical University Hospital · Riga · NCT07814976

• Holmium laser versus electrohydraulic lithotripsy for difficult bile duct and pancreatic duct stones

  This will test whether a low-power holmium laser works and is as safe as electrohydraulic lithotripsy for adults with large or hard-to-remove bile duct or pancreatic duct stones.

  Recruiting Phase 4 Rush University Medical Center · Chicago, Illinois · NCT07418112

• Intraductal antibiotic given during ERCP for acute cholangitis

  This trial tests whether putting an antibiotic directly into the bile ducts during ERCP, together with standard IV antibiotics, helps adults with mild-to-moderate acute cholangitis recover faster and avoid worsening infection compared with IV antibiotics alone.

  Recruiting Phase 2 National University of Malaysia · Cheras, Kuala Lumpur · NCT07407491

• Comparing the carbon footprint of endoscopic ultrasound versus MRCP for suspected common bile duct stones

  This project will test whether endoscopic ultrasound (EUS) produces a smaller carbon footprint than MRCP when used to check for common bile duct (CBD) stones in adults with intermediate risk.

  Recruiting Asian Institute of Gastroenterology, India · Hyderabad, Telangana · NCT07283185

• Early versus late laparoscopic gallbladder removal after clearing common bile duct stones with ERCP

  This trial will test whether having your gallbladder removed soon after ERCP or waiting longer gives better outcomes for people who had stones cleared from their common bile duct.

  Recruiting Khyber Teaching Hospital · Peshawar, Khyberpukhtunkhwa · NCT07130864

• One-stage laparoendoscopic approach for gallbladder and common bile duct stones

  This trial tests whether a single-operation laparoendoscopic 'rendezvous' approach—combining laparoscopic gallbladder removal with endoscopic bile duct clearance—works safely and effectively for patients with both gallbladder and common bile duct stones.

  Recruiting Minia University · Minya · NCT07008170

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.